Portfolio Companies News
September 19, 2019Strongbridge Biopharma plc Announce...
~ RECORLEV Resulted in Sustained Improvements in Urinary Free Cortisol (UFC) and Provided Clinical Benefit, As Demonstrated By Improvements in Comorbidities and Characteristic Signs and Symptoms of Cushing’s Syndrome ~ ~ RECORLEV Was Generally Well-Tolerated, With No Unex... read more
September 18, 2019BONESUPPORT HOLDING AB presents hea...
Lund, Sweden, 19.00 CET, 18 September 2019 – BONESUPPORT HOLDING AB, listed on Nasdaq Stockholm - an emerging leader in orthobiologics for the management of bone voids announced today that health economic data was presented during the EBJIS conference entitled "The economic burden of osteomyeliti... read more
September 17, 2019Nordic Nanovector R&D Day unveils u...
17.09.2019 07:00 Clinical LYMRIT 37-01 (relapsed iNHL) - median duration of response of 13.6 months for all responders and 32.0 months for complete responders versus 9.0 months and 20.7 months respectively reported last December at ASH Archer-1 - 100% ORR (... read more
September 16, 2019Vicore Pharma publishes prospectus ...
Gothenburg,September 16, 2019- On September 11, 2019, Vicore Pharma Holding AB (publ) (”Vicore” or the “Company”) announced that Nasdaq Stockholm’s listing committee had approved that the Company’s shares are admitted to trading on Nasdaq Stockholm’s main market. Today, on Sept... read more
September 15, 2019New Interim Data in RRMM Patients w...
Stockholm – September 15, 2019 – Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today updated interim efficacy and safety data from the ongoing pivotal Phase 2 study, HORIZON, at the 17th International Myeloma Workshop (IMW) meeting in Boston, Massachusetts, USA. The data focused on ... read more
August 01, 2019Q2 2019 General Market Overview
Since the start in 1996, HealthCap funds have invested in 114 portfolio companies.
42 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.